Table 3 Comparison of clinical outcomes at three months between PRP subgroups and exercise group
| Â | t value | Pr(>|t|) |
|---|---|---|
TGF-β < 61.79 μg/ml | ||
 ASES | − 0.173 | 0.864 |
 Constant-Murley score | − 0.474 | 0.639 |
 NRS | − 0.274 | 0.786 |
TGF-β > 61.79 μg/ml | ||
 ASES | − 2.465 | 0.018* |
 Constant-Murley score | − 2.350 | 0.024* |
 NRS | 1.871 | 0.069 |
IL-1β < 5.19 pg/ml | ||
 ASES | − 0.475 | 0.638 |
 Constant-Murley score | − 0.195 | 0.847 |
 NRS | − 0.105 | 0.917 |
IL-1β > 5.19 pg/ml | ||
 ASES | − 2.664 | 0.012* |
 Constant-Murley score | − 3.345 | 0.002* |
 NRS | 2.370 | 0.023* |